News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Agilent Expands Portfolio of Probes for In Situ Hybridization Better signal-to-noise ratio makes data easier to interpret SANTA CLARA, Calif., June 14, 2018 Agilent Technologies Inc. (NYSE: A) today announced the release of a range of new probes for in situ hybridization, a technique used in pathology laboratories to obtain information about gene expression. The... Read more
Vienna, Austria, and Rijswijk, The Netherlands, June 12, 2018 /PRNewswire/ – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples in a... Read more
Co-authored paper, “Ethical Considerations in the Manufacture, Sale and Distribution of Genome-Editing Technologies,” accepted in leading bioethics journal Highlights importance of science-based bioethics in genome editing and novel processes to ensure products meet the highest standards Darmstadt, Germany, June 12, 2018 – Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in... Read more
Agilent Enables CISH on Dako Omnis System can now employ three analytical techniques simultaneously SANTA CLARA, Calif., June 12, 2018 Agilent Technologies Inc. (NYSE: A) today announced the release of a new accessory kit that enables the company’s Dako Omnis system to analyze tissue samples using three different techniques simultaneously. With the new kit, the... Read more
Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and... Read more
ROCKVILLE, Md., June 7, 2018 /PRNewswire/ — Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis. The partnership combines Zymo Research’s complete microbiomics product portfolio from sample collection/preservation, mock microbial community standards, nucleic acid isolation, and library preparation with the largest curated microbiome database maintained and powered by CosmosID. The... Read more
MENLO PARK, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has become faster and more affordable thanks to new multiplexing tools it will feature at the upcoming American Society for Microbiology (ASM) annual meeting in Atlanta. The increased throughput of... Read more
ASM Microbe Conference 2018 includes over 30 abstracts covering QIAGEN Sample to Insight solutions Germantown, Maryland, and Hilden, Germany, June 7, 2018 – QIAGEN today announced the launch of the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit with a new generation of reagents to enable the most accurate microbial community profiling from complex microbiome... Read more
HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE) — The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio). Infecting tens of millions of people worldwide every year, these bacteria have... Read more
Standardizing human sample identification using automated genomic microfluidic systems that reduce hands-on time and cost per sample SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification and quality assessment of human samples and cell lines in disease research. Maintaining accurate chain-of-custody from sample... Read more